Please login to the form below

Not currently logged in
Email:
Password:

Chiltern promotes Richard Pilnik to chairman

He replaces Nick Thornton in the lead role

Chiltern Richard PilnikLondon and North Carolina-based clinical research organisation Chiltern has promoted Richard Pilnik to become its new chairman, succeeding Nick Thornton.

Pilnik became a member of the board of directors in 2015 bringing considerable industry experience across Asia, Europe, Latin America and the US to the firm.

Prior to joining Chiltern, Pilnik served as executive vice president at Quintiles and president of its Commercial Solutions division from 2009 until 2014.

He also brings leadership experience from Eli Lilly, which he joined in 1983 and subsequently held a number of senior positions including president for Europe, Middle East, Africa and CIS, and group vice president and chief marketing officer.

Jim Esinhart, chief executive officer of Chiltern, said: “On behalf of Chiltern's senior executive team and staff, as well as the investors and board of directors, I look forward to continuing to work with Rich in his new position as chairman.

“I would also like to thank Nick Thornton for his exceptional contribution to Chiltern over the past 10 years.”

9th June 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...